1 FTSE 100 stock I’d buy with £1k for 2022

The FTSE 100 stock has been a rewarding one for this Fool in the past. And going by its results today, it could remain so in the near future too!

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Businessman touching on number 2022 for preparation

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

2021 has been a good year for many FTSE 100 stocks. But by the looks of it, it appears that 2022 might be better still. Recovery is underway, Covid-19 is largely under control, and the stock markets are rallying. And here is the best part: the FTSE 100 index, for all its progress, has yet to return to the highs of early 2020. This indicates to me that there is at least some steam in the stock markets still. 

AstraZeneca is pricey but attractive

It does not sound very fashionable at this time to suggest a defensive stock as a great purchase for 2022. But this FTSE 100 stock is a stand-out for me irrespective of where we are in the business cycle. 

I am talking about the Covid-19 vaccine producer AstraZeneca (LSE: AZN), which touched new highs recently. The stock is among the most pricey FTSE 100 stocks, but that doesn’t put me off. I have long liked the stock despite not just its high share price, but also its elevated price-to-earnings (P/E) ratio. Its P/E is 44 times right now.

Massive revenue increase for the FTSE 100 stock

And after its latest third-quarter results released earlier today, I reckon it could continue to do well. Its revenues grew by a huge 50% from the same quarter last year. And its core earnings per share (EPS) increased by 14%. Core earnings are those from ongoing operations as opposed to reported earnings that include the impact of one-off items, like the sale of assets. Its performance in the latest quarter brings its revenue growth for the first nine months of the year to 32% and its core EPS growth to a notable 22%. 

AstraZeneca is also positive in its guidance for 2021. It expects that revenues will grow by a “low-twenties percentage”. If Covid-19 vaccine revenues are added to this in the next quarter, then the revenue growth is expected to jump to “mid-to-high twenties percentage”. It also expects further growth in core EPS.  

Profits from the vaccine?

Moving forward, it is possible that its profits will be positively impacted as well. It has just said that it will start moving away from the provision of Covid-19 vaccines at cost. Sale at cost was part of its agreement with Oxford University, which was its partner in vaccine development. 

Frankly, as an investor in the stock I would have much preferred to see it continue to provide these at cost considering some emerging countries in particular are witnessing low rates of vaccination even now. On the other hand, though, since a number of vaccine alternatives are available, I am not sure if AstraZeneca’s vaccine is as critical as it was a year ago. In any case, AstraZeneca’s pandemic agreements are still expected to constitute much of its vaccine sales next quarter. 

My takeaway

In any case, AstraZeneca’s performance is expected to stay elevated for the foreseeable future. This could continue to push up its share price. I have bought the stock and could buy another 10-11 of its shares for around £1k for 2022 today. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh owns shares of AstraZeneca. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

A profitable penny stock with a well-covered 8% dividend yield! What’s the catch?

Mark Hartley dives into a rare penny stock that offers an 8% dividend yield, investigating whether it deserves a place…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

I slashed my monthly expenses by £300 to help me aim for a steady second income stream of £20k

This Fool's saving an extra £300 a month and investing it in a portfolio of dividends stocks to power his…

Read more »

Workers at Whiting refinery, US
Investing Articles

Come on Shell! Here’s why you could consider buying BP shares…

Following takeover speculation, James Beard’s put together a letter to Shell’s boss explaining why the energy giant could consider buying…

Read more »

National Grid engineers at a substation
Investing Articles

National Grid shares: a £1,000 investment 5 years ago is now worth…

National Grid shares are on the rise! Here’s how much money investors have made so far… and how much they…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Vodafone shares: a £1,000 investment 5 years ago is now worth…

Vodafone shares have underwhelmed since 2020, but could the stock be on the verge of an explosive comeback? Here's what…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Investing £1,000 in BT shares 5 years ago: here’s how much could have been made…

BT shares are on the rise as the company steers itself towards £2bn of free cash flow generation by March…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

£100,000 invested in Tesco shares at the start of 2025 is now worth…

Tesco shares are on the rise as the UK's leading supermarket continues to dominate, but how much money have investors…

Read more »

Abstract 3d arrows with rocket
Investing Articles

This UK growth share turned £1,000 into £5,000!

Contrary to popular belief, there are some phenomenal UK growth shares capable of delivering game-changing returns just waiting to be…

Read more »